Header Logo

Connection

DANIEL MUSHER to Antibodies, Bacterial

Back to Details
This is a "connection" page, showing publications DANIEL MUSHER has written about Antibodies, Bacterial.
DANIEL MUSHER
Connection Strength
3.437
Antibodies, Bacterial
  1. Genetic Control of Antibody Responses to Pneumococcal Capsular Polysaccharides. Clin Infect Dis. 2016 Jan 01; 62(1):132-3.
    View in: PubMed
    Score: 0.436
  2. Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults. Hum Vaccin. 2011 Sep; 7(9):919-28.
    View in: PubMed
    Score: 0.329
  3. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults. J Infect Dis. 2010 Feb 15; 201(4):516-24.
    View in: PubMed
    Score: 0.296
  4. Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. J Infect Dis. 2005 Apr 01; 191(7):1063-7.
    View in: PubMed
    Score: 0.210
  5. Protection against bacteremic pneumococcal infection by antibody to pneumolysin. J Infect Dis. 2001 Mar 01; 183(5):827-30.
    View in: PubMed
    Score: 0.158
  6. Genetic control of the immunologic response to pneumococcal capsular polysaccharides. Vaccine. 2000 Nov 08; 19(6):623-7.
    View in: PubMed
    Score: 0.156
  7. Acute Febrile Illness and Complications Due to Murine Typhus, Texas, USA1,2. Emerg Infect Dis. 2017 08; 23(8):1268-1273.
    View in: PubMed
    Score: 0.124
  8. Emergence of antibody to capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin Infect Dis. 1997 Mar; 24(3):441-6.
    View in: PubMed
    Score: 0.121
  9. Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J Investig Med. 1997 Feb; 45(2):57-68.
    View in: PubMed
    Score: 0.120
  10. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis. 1996 Jun; 173(6):1347-53.
    View in: PubMed
    Score: 0.114
  11. The lack of association between aging and postvaccination levels of IgG antibody to capsular polysaccharides of Streptococcus pneumoniae. Clin Infect Dis. 1996 Jan; 22(1):165-7.
    View in: PubMed
    Score: 0.111
  12. Pneumococcal vaccination for patients with spinal cord injury. Arch Phys Med Rehabil. 1993 Dec; 74(12):1354-7.
    View in: PubMed
    Score: 0.096
  13. Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin Infect Dis. 1993 Jul; 17(1):66-73.
    View in: PubMed
    Score: 0.094
  14. V(H)3 antibody response to immunization with pneumococcal polysaccharide vaccine in middle-aged and elderly persons. Clin Vaccine Immunol. 2011 Mar; 18(3):362-6.
    View in: PubMed
    Score: 0.079
  15. Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect Immun. 1990 Dec; 58(12):3871-6.
    View in: PubMed
    Score: 0.078
  16. Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia. J Infect Dis. 2008 Oct 01; 198(7):1019-27.
    View in: PubMed
    Score: 0.067
  17. Vaccination of 18-month-old children with conjugated polyribosyl ribitol phosphate stimulates production of functional antibody to Haemophilus influenzae type b. Pediatr Infect Dis J. 1988 Mar; 7(3):156-9.
    View in: PubMed
    Score: 0.065
  18. Ig class and IgG subclass responses to Treponema pallidum in patients with syphilis. J Clin Immunol. 1988 Mar; 8(2):128-39.
    View in: PubMed
    Score: 0.065
  19. Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination. J Infect Dis. 1986 Dec; 154(6):935-43.
    View in: PubMed
    Score: 0.059
  20. Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis. 1986 Aug; 154(2):245-56.
    View in: PubMed
    Score: 0.058
  21. Emergence of bactericidal and opsonizing antibody to Vibrio vulnificus following bacterial infection. J Clin Microbiol. 1986 Mar; 23(3):411-5.
    View in: PubMed
    Score: 0.056
  22. Radioimmunoassays for the detection of antibodies to treponemal polypeptide antigens in serum. J Clin Microbiol. 1985 Jun; 21(6):922-9.
    View in: PubMed
    Score: 0.053
  23. Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae. Infect Immun. 1984 Jul; 45(1):36-40.
    View in: PubMed
    Score: 0.050
  24. Spotted-fever-group rickettsioses in north Asia. Lancet. 2004 Mar 27; 363(9414):1076.
    View in: PubMed
    Score: 0.049
  25. Circulating immune complexes in experimental syphilis: identification of treponemal antigens and specific antibodies to treponemal antigens in isolated complexes. Infect Immun. 1983 Nov; 42(2):585-93.
    View in: PubMed
    Score: 0.048
  26. Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Infect Dis. 2001 Jan 15; 32(2):307-10.
    View in: PubMed
    Score: 0.039
  27. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis. 1999 Aug; 29(2):281-8.
    View in: PubMed
    Score: 0.036
  28. IgG responses to protein-conjugated pneumococcal capsular polysaccharides in persons who are genetically incapable of responding to unconjugated polysaccharides. Clin Infect Dis. 1998 Dec; 27(6):1487-90.
    View in: PubMed
    Score: 0.034
  29. Epitope mapping of B-cell determinants on the 15-kilodalton lipoprotein of Treponema pallidum (Tpp15) with synthetic peptides. Infect Immun. 1996 Jul; 64(7):2457-66.
    View in: PubMed
    Score: 0.029
  30. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis. 1996 Jan; 173(1):83-90.
    View in: PubMed
    Score: 0.028
  31. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis. 1992 Mar; 165(3):553-6.
    View in: PubMed
    Score: 0.021
  32. Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis. 1992 Feb; 14(2):403-11.
    View in: PubMed
    Score: 0.021
  33. Pneumococcal vaccination: work to date and future prospects. Am J Med Sci. 1990 Jul; 300(1):45-52.
    View in: PubMed
    Score: 0.019
  34. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis. 1990 Apr; 161(4):728-35.
    View in: PubMed
    Score: 0.019
  35. Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection? J Infect Dis. 1990 Apr; 161(4):736-40.
    View in: PubMed
    Score: 0.019
  36. Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis. 1985 May; 151(5):878-82.
    View in: PubMed
    Score: 0.013
  37. Outer membrane proteins of nontypable Haemophilus influenzae and reactivity of paired sera from infected patients with their homologous isolates. Infect Immun. 1985 Mar; 47(3):843-6.
    View in: PubMed
    Score: 0.013
  38. Evaluation of Sch 29482 in experimental syphilis and comparison with penicillin G benzathine in disseminated disease and localized infection. Antimicrob Agents Chemother. 1984 Sep; 26(3):401-4.
    View in: PubMed
    Score: 0.013
  39. Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae. Ann Intern Med. 1983 Oct; 99(4):444-50.
    View in: PubMed
    Score: 0.012
  40. Immune complexes in experimental syphilis: a methodologic evaluation. Sex Transm Dis. 1982 Oct-Dec; 9(4):170-7.
    View in: PubMed
    Score: 0.011
  41. The role of a vaccine for syphilis. Sex Transm Dis. 1977 Oct-Dec; 4(4):163-6.
    View in: PubMed
    Score: 0.008
  42. The immunology of syphilis. Int J Dermatol. 1976 Oct; 15(8):566-76.
    View in: PubMed
    Score: 0.007
  43. Phagocytosis and killing of common bacterial pathogens of the lung by human alveolar macrophages. J Infect Dis. 1985 Jul; 152(1):4-13.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.